The Pharmacy Workplace and Well-being Reporting portal was developed because pharmacy personnel wanted a venue to address workplace concerns and suggest improvements without fear of retribution.
Qulipta is the first and only oral calcitonin gene-related peptide receptor antagonist (gepant) specifically developed for the preventive treatment of migraine.